Blinding of Participants to Treatment and Implications for Assessments of Efficacy in Attention-Deficit/Hyperactivity Disorder Micronutrient Study
- PMID: 37543078
- DOI: 10.1016/j.jaac.2022.12.029
Blinding of Participants to Treatment and Implications for Assessments of Efficacy in Attention-Deficit/Hyperactivity Disorder Micronutrient Study
Comment in
-
Dr. Johnstone et al. Reply to Dr. Hamilton.J Am Acad Child Adolesc Psychiatry. 2023 Nov;62(11):1168-1170. doi: 10.1016/j.jaac.2023.07.992. Epub 2023 Aug 3. J Am Acad Child Adolesc Psychiatry. 2023. PMID: 37543080 Free PMC article.
Comment on
-
Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial.J Am Acad Child Adolesc Psychiatry. 2022 May;61(5):647-661. doi: 10.1016/j.jaac.2021.07.005. Epub 2021 Jul 22. J Am Acad Child Adolesc Psychiatry. 2022. PMID: 34303786 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
